¼¼°èÀÇ ¿µ»ó Áø´Ü ½ÃÀå
Diagnostic Imaging
»óǰÄÚµå : 1526281
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 537 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,009,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,027,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¿µ»ó Áø´Ü ¼¼°è ½ÃÀåÀº 2030³â±îÁö 410¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2023³â¿¡ 290¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¿µ»ó Áø´Ü ¼¼°è ½ÃÀåÀº 2023-2030³â°£ CAGR 5.0%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 410¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ X¼± ¿µ»óÀº CAGR 4.5%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 94¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. MRI ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ CAGR·Î 5.4%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 88¾ï ´Þ·¯, Áß±¹Àº CAGR 7.2%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¿µ»ó Áø´Ü ½ÃÀåÀº 2023³â¿¡ 88¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 52¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2023-2030³â°£ CAGRÀº 7.2%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î¼­´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 3.2%¿Í 4.4%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.2%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

¼¼°è ¿µ»ó Áø´Ü ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ Á¤¸®

¿µ»ó Áø´ÜÀº Çö´ë ÀÇÇп¡¼­ Áß¿äÇÑ µµ±¸·Î, ºñħ½ÀÀûÀ¸·Î ü³» ±¸Á¶¸¦ ½Ã°¢È­ÇÏ¿© Áúº´À» È¿°úÀûÀ¸·Î Áø´Ü, ¸ð´ÏÅ͸µ ¹× Ä¡·áÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ÀÌ ºÐ¾ß¿¡´Â ¿¢½º·¹ÀÌ, ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(CT), ÀÚ±â°ø¸í¿µ»ó(MRI), ÃÊÀ½ÆÄ, ¾çÀüÀÚ¹æ»ç¼±´ÜÃþÃÔ¿µ(PET) ¹× ´ÜÀϱ¤ÀÚ¹æ»ç¼±´ÜÃþÃÔ¿µ(SPECT)À» Æ÷ÇÔÇÑ ÇÙÀÇÇÐ µî ´Ù¾çÇÑ ±â¼úÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ °Ë»ç¹ýÀº °¢°¢ ¶Ñ·ÇÇÑ ¸ñÀûÀ» °¡Áö°í ÀÖÀ¸¸ç, ƯÁ¤ ÁúȯÀ̳ª °Ë»ç ºÎÀ§¿¡ µû¶ó ¼±Åõ˴ϴÙ. ¿¹¸¦ µé¾î, ¿¢½º·¹ÀÌ´Â »À¸¦ º¸°Å³ª °ñÀýÀ» ¹ß°ßÇÏ´Â µ¥ ÁÖ·Î »ç¿ëµÇÁö¸¸, ¿¬ºÎÁ¶Á÷Àº MRI°¡ ´õ Àß º¼ ¼ö ÀÖ½À´Ï´Ù. ÃÊÀ½ÆÄ °Ë»ç´Â »êºÎÀΰú¿Í ½ÉÀåÇп¡¼­ ÀӽŠÁß Å¾Ƹ¦ °Ë»çÇϰųª ½ÉÀå ±â´ÉÀ» Æò°¡ÇÏ´Â µ¥ ÀÚÁÖ »ç¿ëµË´Ï´Ù. ÇÙÀÇÇÐÀº ÀÎü¿¡ ´ëÇÑ ±â´ÉÀû Á¤º¸¸¦ Á¦°øÇÏ°í ºÐÀÚ È°µ¿À» °¨ÁöÇÏ¿© ´Ù¸¥ ¿µ»ó °Ë»ç·Î ¹àÇôÁö±â Àü¿¡ Áúº´À» Á¶±â¿¡ ¹ß°ßÇÒ ¼ö ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº ¿µ»ó Áø´ÜÀÇ ´É·ÂÀ» ºñ¾àÀûÀ¸·Î Çâ»ó½ÃÄ×½À´Ï´Ù. µðÁöÅÐ À̹ÌÁö ¹× 3D À籸¼º µîÀÇ ±â¼ú Çõ½ÅÀ¸·Î À̹ÌÁö ǰÁúÀÌ Çâ»óµÇ°í ¹æ»ç¼± ÇÇÆøÀÌ °¨¼ÒÇß½À´Ï´Ù. ÀΰøÁö´É(AI)°ú ¿µ»ó ó¸® ±â¼úÀÇ ÅëÇÕÀº ÀÌ ºÐ¾ß¿¡ º¯È­¸¦ °¡Á®¿ÔÀ¸¸ç, AI ¾Ë°í¸®ÁòÀº Àΰ£ÀÇ ´«À¸·Î´Â ³õÄ¥ ¼ö ÀÖ´Â ÆÐÅÏÀ» °¨ÁöÇÏ¿© ¿µ»óÀÇÇаú Àǻ簡 ¾Ï°ú °°Àº Áúº´À» º¸´Ù È¿°úÀûÀ¸·Î Áø´ÜÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÈÞ´ë¿ë ¿µ»ó Áø´Ü ÀåºñÀÇ °³¹ß·Î Áø´Ü ¼­ºñ½ºÀÇ ¹üÀ§°¡ È®´ëµÇ¾î ÀÀ±Þ »óȲÀ̳ª ³óÃÌ ¹× ÀÚ¿øÀÌ ºÎÁ·ÇÑ Áö¿ª¿¡¼­ ƯÈ÷ °¡Ä¡ ÀÖ´Â ÇöÀå Áø·á ¼­ºñ½º¸¦ Á¦°øÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù¼º Çâ»óÀº Àû½Ã¿¡ Áø´Ü°ú Ä¡·á¿¡ ÇʼöÀûÀ̸ç ȯÀÚ °á°ú¿¡ Å« ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ¶ÇÇÑ PET/CT ¹× PET/MRI¿Í °°Àº ÇÏÀ̺긮µå ¿µ»ó Áø´Ü ±â¼úÀÇ ¹ßÀüÀ¸·Î ÇØºÎÇÐÀû ±â´É°ú »ýÈ­ÇÐÀû ±â´ÉÀ» µ¿½Ã¿¡ ¿µ»óÈ­ÇÒ ¼ö ÀÖ°Ô µÇ¾î º¸´Ù Á¾ÇÕÀûÀÎ Æò°¡°¡ °¡´ÉÇØÁ® Áúº´ÀÇ Á¤È®ÇÑ ½Äº°°ú °ü¸®¿¡ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¿µ»ó Áø´Ü ½ÃÀåÀÇ ¼ºÀåÀº ¼¼°è Àα¸ÀÇ °í·ÉÈ­, ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡, ¿µ»ó Áø´Ü ±â¼úÀÇ ¹ßÀü, ÀÇ·áºñ ÁöÃâ Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. Àα¸ °í·ÉÈ­¿Í ÇÔ²² ½ÉÇ÷°ü Áúȯ, ¾Ï, ½Å°æ Àå¾Ö¿Í °°Àº Áúº´ÀÇ ¹ß»ý·üÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ ¸ðµç Áúº´À» È¿°úÀûÀ¸·Î °ü¸®Çϱâ À§Çؼ­´Â ¿µ»ó Áø´ÜÀÌ ÇÊ¿äÇÕ´Ï´Ù. ¸¸¼º Áúȯ ¶ÇÇÑ ¸ðµç ¿¬·ÉÃþ¿¡¼­ ÈçÇØÁö°í ÀÖÀ¸¸ç, ÀæÀº ¸ð´ÏÅ͸µ°ú Æò°¡°¡ ÇÊ¿äÇØ ¿µ»ó Áø´Ü ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ±â¼úÀÇ ¹ßÀüÀº ¿µ»ó Áø´ÜÀÇ Ç°Áú°ú È¿À²¼ºÀ» Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó ±× Àû¿ë ¹üÀ§¸¦ È®ÀåÇÏ°í ´õ ±¤¹üÀ§ÇÑ ÀÓ»ó µµÀÔÀ¸·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Àü ¼¼°è ÀÇ·á ½Ã½ºÅÛÀº ¿¹¹æ ÀÇ·á¿Í Á¶±â Áø´Ü¿¡ ´õ¿í ÁýÁßÇϰí ÀÖÀ¸¸ç, À̴ ÷´Ü ¿µ»ó ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ½ÅÈï±¹À» Áß½ÉÀ¸·Î ÇコÄɾî ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡Çϰí, ÇÏÀ̺긮µå ¹× ÷´Ü ¿µ»ó Áø´Ü ¹æ½ÄÀÌ Á¡Â÷ ¼ö¿ëµÇ°í ÀÖ´Â °Íµµ ÀÌ ½ÃÀåÀÇ °ßÁ¶ÇÑ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌó·³ ¿µ»ó Áø´ÜÀº Çö´ë ÀÇ·á¿¡ ¾ø¾î¼­´Â ¾È µÉ Çʼö ¿ä¼Ò·Î ÀÚ¸®¸Å±èÇϰí ÀÖÀ¸¸ç, Áö¼ÓÀûÀÎ Çõ½ÅÀ» ÅëÇØ ÀÇ·á ¼­ºñ½º Á¦°ø¿¡ ÀÖ¾î ±× ¿ªÇÒÀÌ ´õ¿í È®´ëµÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹(ÃÑ 66°Ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Diagnostic Imaging Market to Reach US$41.0 Billion by 2030

The global market for Diagnostic Imaging estimated at US$29.0 Billion in the year 2023, is expected to reach US$41.0 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2023-2030. X-ray Imaging, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$9.4 Billion by the end of the analysis period. Growth in the MRI segment is estimated at 5.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$8.8 Billion While China is Forecast to Grow at 7.2% CAGR

The Diagnostic Imaging market in the U.S. is estimated at US$8.8 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$5.2 Billion by the year 2030 trailing a CAGR of 7.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Diagnostic Imaging Market - Key Trends & Drivers Summarized

Diagnostic imaging is a critical tool in modern medicine, enabling the visualization of the internal structures of the body non-invasively to diagnose, monitor, and treat medical conditions effectively. This field includes a variety of techniques such as X-ray radiography, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and nuclear medicine including positron emission tomography (PET) and single-photon emission computed tomography (SPECT). Each of these modalities serves distinct purposes and is chosen based on the specific medical conditions and the part of the body being examined. For instance, X-rays are often used for viewing bones and detecting fractures, while soft tissues are better visualized by MRI. Ultrasound is frequently used in obstetrics and cardiology to examine the fetus during pregnancy and assess cardiac functions. Nuclear medicine provides functional information about a person’s body, detecting molecular activity and can pinpoint disease in its earliest stages before they are apparent with other imaging tests.

Technological advancements have vastly improved the capabilities of diagnostic imaging. Innovations such as digital imaging and 3D reconstruction have enhanced image quality and reduced exposure to radiation. The integration of artificial intelligence (AI) with imaging technologies is transforming the field, enabling faster and more accurate analyses of images. AI algorithms help in detecting patterns that may be missed by the human eye, assisting radiologists in diagnosing diseases such as cancer more effectively. Furthermore, the development of portable imaging devices has expanded the reach of diagnostic services, allowing for point-of-care services that are particularly valuable in emergency settings and in rural or under-resourced areas. This accessibility improvement is vital for timely diagnosis and treatment, significantly impacting patient outcomes. Additionally, advances in hybrid imaging techniques, such as PET/CT and PET/MRI, allow for simultaneous imaging of anatomical and biochemical functions, providing a more comprehensive assessment and aiding in precise disease localization and management.

The growth in the diagnostic imaging market is driven by several factors, including the aging global population, the rising prevalence of chronic diseases, technological advancements in imaging modalities, and increasing healthcare expenditure. As the population ages, there is a higher incidence of conditions such as cardiovascular diseases, cancers, and neurological disorders, all of which require diagnostic imaging for effective management. Chronic diseases are also becoming more common across all age groups, necessitating frequent monitoring and evaluation, which supports the demand for imaging services. Technological advancements not only enhance the quality and efficiency of diagnostic imaging but also expand its applications, leading to broader clinical adoption. Additionally, healthcare systems worldwide are focusing more on preventive care and early diagnosis, which further drives the demand for advanced imaging solutions. The increasing investment in healthcare infrastructure, especially in emerging economies, and the growing acceptance of hybrid and advanced imaging modalities contribute to the robust growth of this market. Thus, diagnostic imaging continues to be an indispensable part of modern medical practice, with ongoing innovations ensuring its expanding role in healthcare delivery.

Select Competitors (Total 66 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â